Estimation of treatment effects following a sequential trial of multiple treatments

Whitehead, John and Desai, Yasin and Jaki, Thomas (2020) Estimation of treatment effects following a sequential trial of multiple treatments. Statistics in Medicine, 39 (11). pp. 1593-1609. ISSN 0277-6715

Text (Estimation paper 23-11-19)
Estimation_paper_23_11_19.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.
Download (211kB)

Abstract

When a clinical trial is subject to a series of interim analyses as a result of which the study may be terminated or modified, final frequentist analyses need to take account of the design used. Failure to do so may result in overstated levels of significance, biased effect estimates and confidence intervals with inadequate coverage probabilities. A wide variety of valid methods of frequentist analysis have been devised for sequential designs comparing a single experimental treatment with a single control treatment. It is less clear how to perform the final analysis of a sequential or adaptive design applied in a more complex setting, for example, to determine which treatment or set of treatments amongst several candidates should be recommended. This article has been motivated by consideration of a trial in which four treatments for sepsis are to be compared, with interim analyses allowing the dropping of treatments or termination of the trial to declare a single winner or to conclude that there is little difference between the treatments that remain. The approach taken is based on the method of Rao‐Blackwellization which enhances the accuracy of unbiased estimates available from the first interim analysis by taking their conditional expectations given final sufficient statistics. Analytic approaches to determine such expectations are difficult and specific to the details of the design: instead “reverse simulations” are conducted to construct replicate realizations of the first interim analysis from the final test statistics. The method also provides approximate confidence intervals for the differences between treatments.